Encompass Health Corporation $EHC Shares Sold by BDF Gestion

Key Points

• BDF Gestion has reduced its holdings in Encompass Health Corporation by 9.8% in the second quarter, owning 24,610 shares valued at approximately $3,018,000 after selling 2,682 shares.
• Encompass Health reported a 12.0% increase in revenue compared to the same quarter last year, with earnings per share (EPS) of $1.40, exceeding the consensus estimate of $1.20.
• The company announced a quarterly dividend increase to $0.19 per share, up from the previous $0.17, reflecting a dividend yield of 0.6% and a payout ratio of 13.31%.

BDF Gestion lessened its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 9.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 24,610 shares of the company's stock after selling 2,682 shares during the quarter. BDF Gestion's holdings in Encompass Health were worth $3,018,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in EHC. Deutsche Bank AG grew its position in Encompass Health by 9.9% during the fourth quarter. Deutsche Bank AG now owns 9,814 shares of the company's stock valued at $906,000 after buying an additional 883 shares during the period. ProShare Advisors LLC grew its position in Encompass Health by 7.5% during the fourth quarter. ProShare Advisors LLC now owns 4,713 shares of the company's stock valued at $435,000 after buying an additional 327 shares during the period. Two Sigma Advisers LP grew its position in Encompass Health by 136.3% during the fourth quarter. Two Sigma Advisers LP now owns 63,800 shares of the company's stock valued at $5,892,000 after buying an additional 36,800 shares during the period. Squarepoint Ops LLC grew its position in Encompass Health by 599.0% during the fourth quarter. Squarepoint Ops LLC now owns 127,204 shares of the company's stock valued at $11,747,000 after buying an additional 109,007 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Encompass Health by 18.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 367,598 shares of the company's stock valued at $33,948,000 after purchasing an additional 57,130 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Trading Up 0.4%

Shares of EHC traded up $0.48 during trading on Tuesday, reaching $126.52. 186,204 shares of the company traded hands, compared to its average volume of 796,902. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.86. The stock has a market cap of $12.74 billion, a PE ratio of 24.77, a price-to-earnings-growth ratio of 2.17 and a beta of 0.92. The stock has a 50-day simple moving average of $118.25 and a 200-day simple moving average of $113.99. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business's revenue for the quarter was up 12.0% on a year-over-year basis. During the same period last year, the business earned $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. Encompass Health's dividend payout ratio (DPR) is presently 13.31%.

Analysts Set New Price Targets

Several equities analysts have issued reports on EHC shares. UBS Group increased their price objective on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a report on Thursday, June 5th. KeyCorp increased their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company an "overweight" rating in a report on Tuesday, September 16th. Bank of America increased their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a report on Wednesday, September 10th. Finally, Truist Financial increased their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. Based on data from MarketBeat, Encompass Health presently has an average rating of "Buy" and a consensus price target of $138.43.

Insider Buying and Selling at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.10% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.